Axcelis Technologies (ACLS)
NASDAQ:ACLS

Axcelis Technologies (ACLS) Stock Price & Analysis

960 Followers

ACLS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$46.41 - $136.38
Previous Close$124.73
Volume587.82K
Average Volume (3M)633.37K
Market Cap
$4.23B
Enterprise Value$4.23B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)22.9
Beta1.91
May 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.46
Shares Outstanding32,714,062
10 Day Avg. Volume690,642
30 Day Avg. Volume633,366
Standard Deviation0.15
R-Squared0.41
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)6.31
Price to Sales (P/S)4.58
Price to Cash Flow (P/CF)20.00
P/FCF Ratio20.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.46
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda27.84
Forecast
Price Target Upside16.57% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6


Financials

Annual

Risk Analysis

Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ACLS FAQ

What was Axcelis Technologies’s price range in the past 12 months?
Axcelis Technologies lowest stock price was $46.41 and its highest was $136.38 in the past 12 months.
    What is Axcelis Technologies’s market cap?
    Currently, no data Available
    When is Axcelis Technologies’s upcoming earnings report date?
    Axcelis Technologies’s upcoming earnings report date is May 03, 2023 which is in 35 days.
      How were Axcelis Technologies’s earnings last quarter?
      Axcelis Technologies released its earnings results on Feb 08, 2023. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.29.
        Is Axcelis Technologies overvalued?
        According to Wall Street analysts Axcelis Technologies’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Axcelis Technologies pay dividends?
          Axcelis Technologies does not currently pay dividends.
          What is Axcelis Technologies’s EPS estimate?
          Axcelis Technologies’s EPS estimate is $1.23.
            How many shares outstanding does Axcelis Technologies have?
            Axcelis Technologies has 32,714,060 shares outstanding.
              What happened to Axcelis Technologies’s price movement after its last earnings report?
              Axcelis Technologies reported an EPS of $1.71 in its last earnings report, beating expectations of $1.42. Following the earnings report the stock price went up 5.818%.
                Which hedge fund is a major shareholder of Axcelis Technologies?
                Among the largest hedge funds holding Axcelis Technologies’s share is PRIMECAP Management Co. It holds Axcelis Technologies’s shares valued at 101M.

                  ---

                  Axcelis Technologies Stock Smart Score

                  The Axcelis Technologies stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Axcelis Technologies

                  Axcelis Technologies, Inc. engages in the design, manufacture and service of dry strip, ion implantation and other processing equipment used in the fabrication of semiconductor chips. It provides service and support, including spare parts, equipment upgrades, maintenance services and customer training. The firms' products include Purion H, which is next generation single wafer high current implanter; Optima HDx, is designed to maximize beam current, minimize beam setup time and deliver productive process across the applications space; Purion XE, is next generation single wafer high energy implanter, it is the second tool in the expanding family of Purion ion implanters; Optima XEx, includes implant energies matched to meet the changing needs of today's advanced device manufacturing; Paradigm XE, offers implant energies matched to meet the changing needs of advanced logic and memory manufacturing and Purion M, is a low energy, medium current ion implanter for all channel engineering applications in the low dose and mid dose regimes. It also sells equipment and services through direct sales, distributors and manufacturing representatives. The company was founded in 1978 and is headquartered in Beverly, MA.

                  ---

                  Top 5 ETFs holding ACLS

                  Name
                  Market Value
                  Smart Score
                  Invesco DWA Technology Momentum ETF
                  8
                  Invesco Dynamic Market ETF
                  8
                  Convergence Long/Short Equity ETF
                  8
                  Innovator IBD Breakout Opportunities ETF
                  8
                  Up to five ETFs with an Outperform Smart Score that hold ACLS. The ETFs are listed according to market value of ACLS within the ETF

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Entegris
                  Amkor
                  MKS Instruments
                  Onto Innovation

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis